To Canbiola Management:
I’ve been holding this stock for a very long time and even accumulated lately but while I see many positives, I feel there’s a need for the company to focus and also bring clarity to some of the PR’s and statements made during the shareholders meeting.
I find it very positive that Revenues are growing tremendously for such a small company and am impressed of money raised in the last two private placements, the latest being about $4M at $0.029.
For clarity maybe you can shed some light in a stockholder memo or other public fashion about a few items:
1. SAM’s units – how many have you purchased and what is the adoption rate and usage utilization on a monthly basis? If you have not kept buying additional units per the company’s commitment announced, then why not?
2. Vending machines, what is the strategy? What is the investment of the ordered machines? What is expected revenues? If to place them in doctors’ offices, then I question why visitors wouldn’t just buy the products from the staff instead.
3. Northwell Hospital, is there an agreement with them or are they considered a regular customer? Where in the hospital are the products sold and which products? Does the hospital also sell competing CBD products or does Canbiola have an exclusive?
4. BOD member, advisors et all: What do they bring to the table in return for stock?
5. Expenses and Profit: Even though revenue has exploded so has expenses, will this continue, or do you see a path to profitability/positive cash flow? If so, when?
6. Seed to Oil: what is the strategy for controlling the entire process? Do you envision buying land and starting from scratch or is the goal to purchase/lease parts/all of existing facilities with production capabilities? How about building relationships with growers who can supply raw material?
7. Lab reports: Will these be updated to more current dates?
8. Any plans for product expansion within CBD and beyond (adding THC for example)?
9. Pure Leaf: Any plans of taking this onto Amazon and similar platforms?
10. Nasdaq: what is the strategy of meeting the requirements, especially min stock price and asset and/or revenue requirements? Expected timeline?
11. Investors relations firm: what are they doing to firm up the base and bring new investors?
12. Anything else that you think will benefit shareholders?
I have not sold and continue holding but getting a clearer picture would benefit my self and surely others.
Thanks
